HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fischer, K. C. Articles by Potsaid, M. S. Search for Related Content PubMed PubMed Citation Articles by Fischer, K. C. Articles by Potsaid, M. S.

Improved Brain Scan Specificity Utilizing ^99mTc-Pertechnetate and ^99mTc(Sn)-Diphosphonate

Massachusetts General Hospital, Boston, Massachusetts

Correspondence: For reprints contact: Kenneth McKusick, Dept. of Radiology, Div. of Nuclear Medicine, Massachusetts General Hospital, Boston, Mass. 02114.

ABSTRACT

Each of 36 patients was studied with two separate brain scans performed sequentially after the injection of 20 mCi of ^99mTc-pertechnetate or 20 mCi of ^99mTc(Sn)-diphosphonate. The resulting scans were qualitatively compared, and lesion-to-nonlesion ratios of activity determined. Diagnoses were established by clinical criteria and were supported in the majority of cases by computerized axial tomography or roentgen angiography or both. Histologic confirmation was available in five cases of tumor and in the single cases of subdural hematoma and cerebral abscess. Of 22 cerebral infarctions, 15 were better demonstrated with ^99mTc-(Sn)-diphosphonate than with ^99mTc-pertechnetate. Of the seven remaining cases, three were visualized equally well with each agent, and three were better demonstrated with ^99mTc-pertechnetate. One was not seen with either agent. Of the 12 tumors, 11 were visualized better with ^99mTc-pertechnetate than with ^99mTc(Sn)-diphosphonate while in one case the lesion was seen equally as well with both agents. in no case was a lesion definitely seen with one radio pharmaceutical and not with the other. These results indicate that this dual method is helpful in differentiating gliomas and metastases from cerebral infarctions.